LAUSR

Impact of the PNPLA3 genotype on the risk of hepatocellular carcinoma after hepatitis C virus eradication

Sign Up to like & get
recommendations!
1 Published in 2022 at "Journal of Medical Virology"

DOI: 10.1002/jmv.27904

Abstract: Almost all chronic hepatitis C (CHC) patients can achieve sustained virological response (SVR) with direct‐acting antivirals. However, the development of hepatocellular carcinoma (HCC), even after the achievement of SVR, continues to be a serious problem.… read more here.

Keywords: hepatocellular carcinoma; genotype; hepatitis; pnpla3 genotype ... See more keywords

Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals

Sign Up to like & get
recommendations!
1 Published in 2022 at "Cancers"

DOI: 10.3390/cancers14030828

Abstract: Simple Summary In the present study we investigated the ability of different non-invasive scoring systems (i.e., Forns index, APRI, FIB-4, ALBI, and aMAP) to predict hepatocellular carcinoma development in a large cohort of patients with… read more here.

Keywords: hepatocellular carcinoma; non invasive; development; hcc ... See more keywords